课件：术后支架内血栓形成及预防.ppt

INT.CLO.04.02.01 NOT FOR DISTRIBUTION/ FOR INTERNAL USE ONLY Please note that neither Sanofi-Synthelabo nor Bristol-Myers Squibb recommends the use of clopidogrel in any manner inconsistent with that described in the full prescribing information. * Premature discontinuation of antiplatelet therapy was a major significant univariate predictor of stent thrombosis. The cumulative incidence of thrombosis was 29% (5 of 17 patients), with a hazard ratio of 152 (95% Confidence interval; 52 to 442; P0.001); clopidogrel was discontinued in one patient. Other significant univariate predictors included